Vivos Therapeutics (VVOS) EPS (Basic) (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly EPS (Basic) came in at -$0.31 in Q2 2026, up 43.81% year-over-year from -$0.22 in Q2 2025, and up 40.95% quarter-over-quarter from -$0.52 in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) EPS (Basic) (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported EPS (Basic) for 7 consecutive years, with -$0.31 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 43.81% year-over-year to -$0.31 in Q2 2026; TTM through Jun 2026 was -$1.44, a 8.79% increase from a year earlier, with the FY2025 full-year figure at -$2.07, up 7.33% from the prior year.
- EPS (Basic) was -$0.31 for Q2 2026 at Vivos Therapeutics, up from -$0.52 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.31 in Q2 2026 and troughed at -$8.23 in Q2 2022.
- A 5-year average of -$2.52 and a median of -$1.15 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 68.91% in 2022 and soared 87.05% in 2024, its largest moves.
- Over 5 years, EPS (Basic) stood at -$6.61 in 2022, then jumped by 46.67% to -$3.53 in 2023, then soared by 83.71% to -$0.57 in 2024, then decreased by 17.77% to -$0.68 in 2025, then soared by 54.2% to -$0.31 in 2026.
- The last three EPS (Basic) figures came in at -$0.31 (Q2 2026), -$0.52 (Q1 2026), and -$0.68 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 1.51 |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 0.33 |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 0.18 |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | -0.01 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 0.00 |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -0.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.31 |
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.68 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -1.63 |
| Dec 31, 2023 | -3.53 |
| Sep 30, 2023 | -1.75 |
| Jun 30, 2023 | -4.62 |
| Mar 31, 2023 | -1.72 |
| Dec 31, 2022 | -6.61 |
| Sep 30, 2022 | -6.40 |
| Jun 30, 2022 | -8.23 |
| Mar 31, 2022 | -6.28 |
| Dec 31, 2021 | -8.70 |
| Sep 30, 2021 | -6.55 |